References

Ohio Prevention and Treatment of Endometrial Cancer Initiative Study Group. Up-front multigene panel testing for cancer susceptibility in patients with newly diagnosed endometrial cancer: a multicenter prospective study

10.1200/po.21.00249 · 2021 · External reference

Comprehensive analysis of germline drivers in endometrial cancer

10.1093/jnci/djad016 · 2023 · External reference

Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer

10.1016/j.ygyno.2022.05.023 · 2022 · External reference

Pathogenic germline variants among women with uterine cancer by ancestry: a commercial laboratory collaborative research registry study

10.1016/j.ygyno.2025.04.585 · 2025 · External reference

A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients

10.1016/j.annepidem.2007.03.011 · 2007 · External reference

The development of a standardized neighborhood deprivation index

10.1007/s11524-006-9094-x · 2006 · External reference

Unresolved reference

2021 · External reference

The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis

10.1038/s41436-019-0536-8 · 2019 · External reference

Unresolved reference

External reference

Germline mutations of the DNA repair pathways in uterine serous carcinoma

10.1016/j.ygyno.2015.12.034 · 2016 · External reference

Frequent homologous recombination deficiency in high-grade endometrial carcinomas

10.1158/1078-0432.ccr-18-1443 · 2019 · External reference

Clinical multigene panel testing identifies racial and ethnic differences in germline pathogenic variants among patients with early-onset colorectal cancer

10.1200/jco.22.02378 · 2023 · External reference